$MOH
MOLINA HEALTHCARE, INC.

2014 Q1 Form 10-Q Financial Statement

#000117992914000014 Filed on May 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $2.069B $1.590B
YoY Change 30.11% 15.78%
Cost Of Revenue $1.762B $1.328B
YoY Change 32.73% 19.79%
Gross Profit $306.9M $262.7M
YoY Change 16.83% 25.93%
Gross Profit Margin 14.83% 16.52%
Selling, General & Admin $262.0M $178.3M
YoY Change 46.94% 13.28%
% of Gross Profit 85.37% 67.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.99M $21.80M
YoY Change 51.36% 18.87%
% of Gross Profit 10.75% 8.3%
Operating Expenses $282.7M $194.8M
YoY Change 45.12% 13.12%
Operating Profit $24.00M $67.87M
YoY Change -64.64% 103.09%
Interest Expense $13.82M $13.04M
YoY Change 6.02% 203.33%
% of Operating Profit 57.59% 19.21%
Other Income/Expense, Net -$13.78M -$12.91M
YoY Change 6.76% 200.28%
Pretax Income $10.49M $54.97M
YoY Change -80.92% 88.75%
Income Tax $5.655M $24.45M
% Of Pretax Income 53.91% 44.47%
Net Earnings $4.000M $29.92M
YoY Change -86.63% 65.38%
Net Earnings / Revenue 0.19% 1.88%
Basic Earnings Per Share $0.10 $0.65
Diluted Earnings Per Share $0.09 $0.64
COMMON SHARES
Basic Shares Outstanding 46.02M shares 45.98M shares
Diluted Shares Outstanding 47.52M shares 46.44M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.780B $1.512B
YoY Change 17.74% 72.6%
Cash & Equivalents $1.083B $1.170B
Short-Term Investments $696.2M $341.9M
Other Short-Term Assets $112.9M $39.58M
YoY Change 185.31% 2.27%
Inventory
Prepaid Expenses
Receivables $338.2M $150.3M
Other Receivables $28.10M $0.00
Total Short-Term Assets $2.281B $1.727B
YoY Change 32.09% 49.92%
LONG-TERM ASSETS
Property, Plant & Equipment $310.4M $237.7M
YoY Change 30.55% 19.71%
Goodwill $230.7M $151.1M
YoY Change 52.72%
Intangibles
YoY Change
Long-Term Investments $10.90M $13.60M
YoY Change -19.85% -15.53%
Other Assets $39.73M $29.45M
YoY Change 34.91% -76.65%
Total Long-Term Assets $1.012B $761.1M
YoY Change 33.01% 29.43%
TOTAL ASSETS
Total Short-Term Assets $2.281B $1.727B
Total Long-Term Assets $1.012B $761.1M
Total Assets $3.293B $2.488B
YoY Change 32.37% 42.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $406.4M $160.0M
YoY Change 154.0% 28.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $183.7M $1.167M
YoY Change 15642.33% 6.09%
Total Short-Term Liabilities $1.556B $803.0M
YoY Change 93.76% 18.6%
LONG-TERM LIABILITIES
Long-Term Debt $615.6M $642.0M
YoY Change -4.11% 181.33%
Other Long-Term Liabilities $27.74M $23.84M
YoY Change 16.35% 7.38%
Total Long-Term Liabilities $27.74M $665.8M
YoY Change -95.83% 165.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.556B $803.0M
Total Long-Term Liabilities $27.74M $665.8M
Total Liabilities $2.396B $1.724B
YoY Change 38.97% 78.7%
SHAREHOLDERS EQUITY
Retained Earnings $557.6M $530.1M
YoY Change 5.19%
Common Stock $340.4M $234.2M
YoY Change 45.34%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $897.7M $764.2M
YoY Change
Total Liabilities & Shareholders Equity $3.293B $2.488B
YoY Change 32.37% 42.99%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $4.000M $29.92M
YoY Change -86.63% 65.38%
Depreciation, Depletion And Amortization $32.99M $21.80M
YoY Change 51.36% 18.87%
Cash From Operating Activities $210.9M $20.10M
YoY Change 949.03% -60.25%
INVESTING ACTIVITIES
Capital Expenditures -$17.80M -$11.20M
YoY Change 58.93% -17.04%
Acquisitions $0.00 $0.00
YoY Change
Other Investing Activities $547.0K -$10.00M
YoY Change -105.47% -65.75%
Cash From Investing Activities -$27.49M -$21.20M
YoY Change 29.67% -50.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $50.00M
YoY Change -100.0%
Debt Paid & Issued, Net $0.00 $291.0K
YoY Change -100.0% -3.32%
Cash From Financing Activities -$35.93M $374.8M
YoY Change -109.59% 2237.03%
NET CHANGE
Cash From Operating Activities $210.9M $20.10M
Cash From Investing Activities -$27.49M -$21.20M
Cash From Financing Activities -$35.93M $374.8M
Net Change In Cash $147.5M $373.7M
YoY Change -60.54% 1464.03%
FREE CASH FLOW
Cash From Operating Activities $210.9M $20.10M
Capital Expenditures -$17.80M -$11.20M
Free Cash Flow $228.7M $31.30M
YoY Change 630.57% -51.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
319965000 USD
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
406414000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1086000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-382000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
340429000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
340848000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5596000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4421000 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6314000 USD
CY2013Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3723000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
651000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1248000 USD
CY2013Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
608000000 USD
CY2014Q1 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
592000000 USD
CY2014Q1 us-gaap Assets
Assets
3293481000 USD
CY2013Q4 us-gaap Assets
Assets
3002937000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2039664000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
2281231000 USD
CY2013Q4 us-gaap Auction Rate Securities Noncurrent
AuctionRateSecuritiesNoncurrent
10898000 USD
CY2014Q1 us-gaap Auction Rate Securities Noncurrent
AuctionRateSecuritiesNoncurrent
10928000 USD
CY2014Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
707454000 USD
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
715702000 USD
CY2014Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
707128000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
713950000 USD
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
306531000 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
199654000 USD
CY2013Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
44529000 USD
CY2014Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
55383000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
366550000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
366567000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11400000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
10928000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
707454000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
329504000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
329633000 USD
CY2014Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
707128000 USD
CY2014Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4265000 USD
CY2013Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
935895000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1083369000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1169511000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
795770000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
373741000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
147474000 USD
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
53.8475
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46263000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45871000 shares
CY2014Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
46000 USD
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
46000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30175000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5202000 USD
CY2013Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
0 USD
CY2014Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
7775000 USD
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
416368000 USD
CY2014Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
421004000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
1522526000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
2044976000 USD
CY2013Q4 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
45675000 USD
CY2014Q1 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year
CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear
44740000 USD
CY2014Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13490236 shares
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
598240000 USD
CY2014Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
604553000 USD
CY2014Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
737000000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
737000000 USD
CY2014Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
132447000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
138760000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
146276000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
122216000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
26556000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
22414000 USD
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3510000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
580000 USD
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16563000 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20691000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21799000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32994000 USD
CY2014Q1 us-gaap Derivative Assets
DerivativeAssets
196617000 USD
CY2013Q4 us-gaap Derivative Assets
DerivativeAssets
186351000 USD
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2000 USD
CY2013Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
119000 USD
CY2014Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2000 USD
CY2013Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
119000 USD
CY2013Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
186239000 USD
CY2014Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
196503000 USD
CY2013Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-200000 USD
CY2014Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-400000 USD
CY2013Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
27092000 USD
CY2014Q1 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
34820000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M18D
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
877000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1177000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
42000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
98871000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93587000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
950000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
188087000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
141278000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
230738000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
230738000 USD
CY2014Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
3258000 USD
CY2013Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
4694000 USD
CY2013Q1 us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
1497433000 USD
CY2014Q1 us-gaap Health Care Organization Premium Revenue
HealthCareOrganizationPremiumRevenue
1940337000 USD
CY2014Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
82036000 USD
CY2014Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5083000 USD
CY2014Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
5079000 USD
CY2014Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
76963000 USD
CY2014Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
76957000 USD
CY2014Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
82046000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4834000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
30522000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
54967000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10489000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.66
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.10
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.65
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-607000 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-336000 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5655000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24445000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
481000 USD
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
14712000 USD
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
28100000 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
32742000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102217000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-31847000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4642000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8424000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Charges Investing
IncreaseDecreaseInDeferredChargesInvesting
6145000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Charges Investing
IncreaseDecreaseInDeferredChargesInvesting
-1756000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
16000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
670000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
24060000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5994000 USD
CY2013Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
-3385000 USD
CY2014Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
149754000 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
117000 USD
CY2013Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
408000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8956000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78023000 USD
CY2014Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
39297000 USD
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
569000 USD
CY2013Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
11016000 USD
CY2014Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
14381000 USD
CY2013Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
902000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
597000 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
462000 shares
CY2014Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1629000 USD
CY2013Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
1516000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
13822000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
13037000 USD
CY2013Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6250000 USD
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
9614000 USD
CY2013Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2527000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear
5434443000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
-50904000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
-58427000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
-52779000 USD
CY2014Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3300000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
17065000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
6388000 USD
CY2014Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-3023000 USD
CY2013Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1502000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
2110000000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
2395761000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3002937000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3293481000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1293976000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1555944000 USD
CY2014Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
819541000 USD
CY2013Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
669787000 USD
CY2012Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
494530000 USD
CY2013Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
491145000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid
1544114000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid
1284501000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid
5317674000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear
4932195000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear
1172672000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear
948820000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears
335681000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears
371442000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears
385479000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims
1722428000 USD
CY2013 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims
5381664000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims
1288754000 USD
CY2013Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear
1347181000 USD
CY2014Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear
1773332000 USD
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
737000000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
182008000 USD
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
183713000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
550000000 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
187000000 USD
CY2014Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
696200000 USD
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
703052000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35932000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
374837000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21200000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27491000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20104000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
210897000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
4498000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
29915000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13778000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12906000 USD
CY2014Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
24267000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
67873000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
42484000 USD
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
112916000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35564000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39730000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
260000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
704000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1426000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
419000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
722000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
159000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26351000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27736000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131000 USD
CY2014Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 USD
CY2013Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
149331000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
CY2014Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
38119000 USD
CY2014Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
17788000 USD
CY2013Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
11167000 USD
CY2014Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
142145000 USD
CY2013Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
76012000 USD
CY2013Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
1287915000 USD
CY2014Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
1721658000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
537973000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
235000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1330000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
75074000 USD
CY2013Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
147370000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5715000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2014Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-20000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
75647000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
310364000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
292083000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
298935000 USD
CY2014Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
338232000 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
291000 USD
CY2013Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
40000000 USD
CY2014Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2014Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
339800000 USD
CY2013Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
365200000 USD
CY2014Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
82036000 USD
CY2013Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
63093000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
553129000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
557627000 USD
CY2014Q1 us-gaap Revenues
Revenues
2069243000 USD
CY2013Q1 us-gaap Revenues
Revenues
1590399000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5596000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4421000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6125 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
27.36
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
628936 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
36.46
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1299852 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1361256 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
33.12
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.03
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
561407 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
20900000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
13100000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
27.46
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
292471 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4475000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
327471 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
379221 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
4475000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
327471 shares
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4325000 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M0D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y6M0D
CY2013Q4 us-gaap Shares Outstanding
SharesOutstanding
45871000 shares
CY2012Q4 us-gaap Shares Outstanding
SharesOutstanding
46762000 shares
CY2014Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
200000 USD
CY2014Q1 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
641000000 USD
CY2014Q1 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
410000000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
391000 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
51750 shares
CY2013Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
50000000 USD
CY2014Q1 moh Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments
744000 USD
CY2013Q4 moh Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments
1316000 USD
CY2014Q1 moh Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments
541000 USD
CY2014Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
47300000 USD
CY2013Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4644000 USD
CY2014Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
8217000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
892937000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
897720000 USD
CY2014Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
4800000 USD
CY2014Q1 us-gaap Technology Services Costs
TechnologyServicesCosts
40657000 USD
CY2013Q1 us-gaap Technology Services Costs
TechnologyServicesCosts
39770000 USD
CY2014Q1 us-gaap Technology Services Revenue
TechnologyServicesRevenue
53630000 USD
CY2013Q1 us-gaap Technology Services Revenue
TechnologyServicesRevenue
49756000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2000000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8000000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
6000000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
70000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
80000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1800000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5700000 USD
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46443000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47520000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45981000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46021000 shares
CY2013Q1 moh Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
3723000 USD
CY2014Q1 moh Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation
AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation
6674000 USD
CY2014Q1 moh Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
33400000 USD
CY2013Q4 moh Anticipated Medicare Risk Adjustment Premiums
AnticipatedMedicareRiskAdjustmentPremiums
20800000 USD
CY2013Q4 moh Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments
1049000 USD
CY2014Q1 moh Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
959000 USD
CY2013Q4 moh Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
613000 USD
CY2013Q4 moh Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions
174 Security
CY2014Q1 moh Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions
143 Security
CY2013Q4 moh Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions
57 Security
CY2013Q1 moh Premium Tax Expenses
PremiumTaxExpenses
37000000 USD
CY2014Q1 moh Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions
56 Security
CY2014Q1 moh Availableforsale Securities Gross Unrealized Loss Accumulated In Investments
AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1285000 USD
CY2013Q4 moh Availableforsale Securities Gross Unrealized Loss Accumulated In Investments
AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
2365000 USD
CY2014Q1 moh Class Of Warrant Or Right Trading Days Measurement Period
ClassOfWarrantOrRightTradingDaysMeasurementPeriod
P160D
CY2014Q1 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
22190000 USD
CY2013Q1 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
0 USD
CY2014Q1 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
18696000 USD
CY2013Q1 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
0 USD
CY2013Q1 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
37000000 USD
CY2014Q1 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
51693000 USD
CY2014Q1 moh Health Insurers Aca Fees Liability Estimated Annual Liabilityin Current Year
HealthInsurersACAFeesLiabilityEstimatedAnnualLiabilityinCurrentYear
88800000 USD
CY2014Q1 moh Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
159754000 USD
CY2013Q4 moh Lease Financing Obligations Noncurrent
LeaseFinancingObligationsNoncurrent
159394000 USD
CY2014Q1 moh Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service
MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService
P2Y
CY2014Q1 moh Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
122700000 USD
CY2013Q4 moh Medical Claimsand Benefits Payable
MedicalClaimsandBenefitsPayable
151300000 USD
CY2014Q1 moh Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
-28560000 USD
CY2013 moh Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
111267000 USD
CY2013Q1 moh Medical Claimsand Benefits Payable Adjustments Changein Provider
MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider
-7638000 USD
CY2014Q1 moh Number Of Categories For Component Of Premium Revenue
NumberOfCategoriesForComponentOfPremiumRevenue
2 category
CY2013Q1 moh Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
0.118
CY2014Q1 moh Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
0.076
CY2013 moh Policy Holder Benefits Prior Percentage
PolicyHolderBenefitsPriorPercentage
0.107
CY2013Q1 moh Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
0.011
CY2014Q1 moh Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
0.009
CY2013 moh Policy Holder Medical Care Cost Prior Year Percentage
PolicyHolderMedicalCareCostPriorYearPercentage
0.010
CY2014Q1 moh Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
0.008
CY2013Q1 moh Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
0.010
CY2013 moh Policy Holder Premium Revenue Prior Year Percentage
PolicyHolderPremiumRevenuePriorYearPercentage
0.009
CY2014Q1 moh Premium Tax Expenses
PremiumTaxExpenses
51693000 USD
CY2014Q1 moh Retirement Of Treasury Stock
RetirementOfTreasuryStock
0 USD
CY2013Q1 moh Retirement Of Treasury Stock
RetirementOfTreasuryStock
53000000 USD
CY2013Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Pair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodPairValue
19300000 USD
CY2014Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Pair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodPairValue
22900000 USD
CY2013Q4 moh Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingIntrinsicValue
USD
CY2014Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
22.77
CY2014Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
25.69
CY2013Q4 moh Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue
24.14
CY2014Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue
23.90
CY2014Q1 moh Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue
23.90
CY2014Q1 moh Weighted Average Numberof Shares Common Stock Repurchased
WeightedAverageNumberofSharesCommonStockRepurchased
0 shares
CY2013Q1 moh Weighted Average Numberof Shares Common Stock Repurchased
WeightedAverageNumberofSharesCommonStockRepurchased
867000 shares
CY2013Q1 moh Weighted Average Numberof Shares Issued
WeightedAverageNumberofSharesIssued
86000 shares
CY2014Q1 moh Weighted Average Numberof Shares Issued
WeightedAverageNumberofSharesIssued
150000 shares
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001179929
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46264000 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
MOLINA HEALTHCARE INC
CY2014Q1 dei Trading Symbol
TradingSymbol
moh

Files In Submission

Name View Source Status
0001179929-14-000014-index-headers.html Edgar Link pending
0001179929-14-000014-index.html Edgar Link pending
0001179929-14-000014.txt Edgar Link pending
0001179929-14-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
moh-20140331.xml Edgar Link completed
moh-20140331.xsd Edgar Link pending
moh-20140331x10q.htm Edgar Link pending
moh-20140331_cal.xml Edgar Link unprocessable
moh-20140331_def.xml Edgar Link unprocessable
moh-20140331_lab.xml Edgar Link unprocessable
moh-20140331_pre.xml Edgar Link unprocessable
moh-2014x03x31xex311.htm Edgar Link pending
moh-2014x03x31xex312.htm Edgar Link pending
moh-2014x03x31xex321.htm Edgar Link pending
moh-2014x03x31xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending